SSG
IDXX icon

Summit Securities Group’s Idexx Laboratories IDXX Stock Holding History

Summit Securities Group’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-241
Closed -$163K – 1205
2025
Q4 		$163K Buy
241
+214
+793% +$146K 0.02% 376
2025
Q3 		$17.3K Buy
+27
New +$16.4K ﹤0.01% 800
2025
Q1 		– Sell
-13
Closed -$5.38K – 931
2024
Q4 		$5.38K Buy
+13
New +$5.7K ﹤0.01% 512
2024
Q3 		– Sell
-11
Closed -$5K – 712
2024
Q2 		$5K Buy
+11
New +$5.52K ﹤0.01% 496
2024
Q1 		– Sell
-7
Closed -$4K – 672
2023
Q4 		$4K Sell
7
-2
-22% -$939 ﹤0.01% 577
2023
Q3 		$4K Sell
9
-20
-69% -$9.97K ﹤0.01% 482
2023
Q2 		$15K Buy
+29
New +$13.9K ﹤0.01% 704
2023
Q1 		– Sell
-1
Closed – – 1039
2022
Q4 		$0 Sell
1
-326
-100% -$127K ﹤0.01% 1245
2022
Q3 		$107K Buy
+327
New +$120K 0.01% 515
2022
Q2 		– Sell
-382
Closed -$209K – 1079
2022
Q1 		$209K Buy
+382
New +$201K 0.02% 374

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Summit Securities Group's IDXX Position: Q1 2026 in Review

Summit Securities Group sold out of Idexx Laboratories (IDXX) in Q1 2026, closing a stake of 241 shares — an estimated $163K sold.

Summit Securities Group first reported a position in IDXX in Q1 2022 and held it in 10 quarters. The position peaked at $209K in Q1 2022. 1,316 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Summit Securities Group reported no remaining Idexx Laboratories position as of Q1 2026 after selling out during the quarter.
  • Summit Securities Group sold 241 Idexx Laboratories shares in Q1 2026, an estimated $163K.
  • Summit Securities Group first reported a position in Idexx Laboratories in Q1 2022 and held it in 10 quarters.
  • Summit Securities Group's Idexx Laboratories position peaked at $209K in Q1 2022.
  • 1,316 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Summit Securities Group's 13F filing for Q1 2026, filed 30 Apr 2026.